Sector portfolio · Asset manager · United States

Perceptive Advisors' Pharma portfolio

Perceptive Advisors has backed 18 Pharma startups in rounds we track, $2.5B between them, shown by the stage each has reached. The best-funded is Zenas Biopharma.

18startups backed
4stages
$2.5Braised between them
Stage not reportedbiggest stage

Perceptive Advisors's whole portfolioPerceptive Advisors's profile

Stage not reported

11

Series C and later

3

Series B

2

Series A

2

Segment by segment

Stage not reported

11 startups · $1.3B raised

  1. IInhibrxUnited States$265M
  2. Zentalis PharmaceuticalsZentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.United States$236M
  3. Edgewise TherapeuticsEdgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.United States$200M
  4. Day One BiopharmaceuticalsDay One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.United States$175M
  5. Point BiopharmaPoint Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.United States$125M
  6. HilleVaxHilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.United States$100M
  7. Mereo BiopharmaMereo is a new UK-based speciality biopharmaceutical company.United Kingdom$92M
  8. EUSA PharmaEUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.United Kingdom$54M

Series C and later

3 startups · $737M raised

  1. Zenas BioPharmaZenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.United States$420M
  2. Poseida TherapeuticsPoseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.United States$217M
  3. Avalyn PharmaAvalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.United States$100M

Series B

2 startups · $317M raised

  1. KardiganKardigan is a heart health company developing drugs designed to make cardiovascular disease curable, preventable, and no longer thUnited States$254M
  2. Rain OncologyRain Oncology is a clinical-stage company focusing on research and development of innovative therapies for cancer patients.-$63M

Series A

2 startups · $103M raised

  1. NeurosterixNeurosterix is a Geneva-based biopharmaceutical company founded in 2024, specializing in the development of next-generation allostSwitzerland$63M
  2. Sermonix PharmaceuticalsSermonix Pharmaceuticals is a biopharmaceutical company based in Columbus, Ohio, founded in 2014 by Dr.United States$40M

How this map is made. Every startup here works in Pharma and has raised money in a round we track that names Perceptive Advisors as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioPerceptive Advisors' Biotech portfolio101 startups · $24BPortfolio mapPerceptive Advisors portfolio map133 startups · $28BCo-investorsWho invests with Perceptive Advisors116 co-investorsSector portfolioBlackRock's AI portfolio41 startups · $529BSector portfolioBlackRock's Fintech portfolio25 startups · $17BSector portfolioBlackRock's Biotech portfolio19 startups · $4.2B

Raising from investors like Perceptive Advisors?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps